Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: AMG 701 Expanded Access Program
The AMG 701 expanded access program has ended and is no longer available to patients.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma [NA]
This document describes a clinical trial evaluating ACT-001, an allogeneic anti-BCMA/GPRC5D bispecific CAR-NK cell therapy, for relapsed or …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma [Phase 1, Phase 2]
This entry summarizes a Phase 1/2 clinical trial evaluating ixazomib in combination with pomalidomide, clarithromycin, and dexamethasone for…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Intestinal Flora and Immunity in Monoclonal Gammopathy Patients
An ongoing clinical trial from Zhujiang Hospital is evaluating whether gut microbiota modulates immune responses in patients with monoclonal…
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma [NA]
A multicenter Phase 2 trial evaluating subcutaneous isatuximab in combination with bortezomib, lenalidomide, and dexamethasone for newly dia…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease. [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating ixazomib for prophylaxis of chronic graft-versus-host disease after hematopoietic stem cell transplantat…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Clinical Study of CD38\CS1 Chimeric Antigen Receptor T Cells in the Treatment of Refractory/Recurrent Multiple Myeloma [EARLY_Phase 1]
This entry reports an early-phase study evaluating CD38-CS1 CAR-T cells for refractory or recurrent multiple myeloma, sponsored by The Secon…
-
CLINICAL_TRIALS research · 2024-08-19Clinical Trial Update: FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM) [Phase 3]
Phase 3 clinical trial (HOVON174MM) evaluating a treatment-free interval in newly diagnosed multiple myeloma patients treated with daratumum…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma [NA]
A completed clinical trial update examining whether dysregulated glutamine metabolism contributes to the pathogenesis of multiple myeloma. T…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: DAratumumab and REvlimid REfractory MM
A clinical trial evaluating daratumumab in combination with lenalidomide (Revlimid) for relapsed/refractory multiple myeloma is currently re…
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study [Phase 1]
Phase 1 study evaluating the safety and PK/PD of OriCAR-017 in subjects with relapsed/refractory multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Early Integration of Palliative and Supportive Care in Cellular Therapy [NA]
This clinical trial is evaluating early integration of palliative and supportive care in cellular therapy for hematologic cancers and is cur…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Update on cytogenetic studies in acute leukemia and multiple myeloma; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2024-07-25Clinical Trial Update: BCMA CAR-T Cell Therapy in High-risk NDMM Patients With Positive MRD After First-line ASCT [Phase 2]
A Phase 2 clinical trial evaluating BCMA CAR-T cell therapy in high-risk newly diagnosed multiple myeloma patients who remain MRD-positive a…
-
CLINICAL_TRIALS research · 2024-07-25Clinical Trial Update: Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients [Phase 3]
Phase 3 clinical trial comparing EAP and CG regimens for mobilizing hematopoietic stem cells in patients with multiple myeloma; currently re…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 clinical trial to assess the safety of HDP-101 in patients with relapsed or refractory multiple myeloma; the study is currently …
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Integrative Therapies in Multiple Myeloma [NA]
A clinical trial update indicates a study evaluating integrative therapies for multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM [NA]
A recruiting study is evaluating the safety and efficacy of Anti-BCMA-GPRC5D CAR-T cell therapy for relapsed/refractory multiple myeloma.
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating nanobody-based Biepitope CAR-T cells targeting BCMA for relapsed/refractory multiple myeloma. The stud…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma [Phase 1]
A Phase 1 study evaluating QLS4131 for relapsed or refractory multiple myeloma, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating curcumin and piperine in patients under surveillance for monoclonal gammopathy, smoldering multiple myelom…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients [Phase 2]
A Phase 2 clinical trial is investigating treosulfan (Trecondi Ideogen) in patients with multiple myeloma, and the study is currently recrui…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab) [Phase 2]
Phase 2 clinical trial PRONTO studies prophylactic versus on-demand use of tocilizumab, currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment
This clinical trial update describes a perspective study evaluating MRD-tailored therapy for patients with newly diagnosed multiple myeloma …
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"
ClinicalTrials.gov update shows ongoing recruitment for a study titled 'Living With a Myeloma in West-Occitanie' focusing on patients with m…